TY - JOUR
T1 - Correlating diffusion-weighted MRI intensity with type 2 pathology in mixed MM-type sporadic Creutzfeldt-Jakob disease
AU - Ikeda, Toshimasa
AU - Iwasaki, Yasushi
AU - Sakurai, Keita
AU - Akagi, Akio
AU - Riku, Yuichi
AU - Mimuro, Maya
AU - Miyahara, Hiroaki
AU - Kitamoto, Tetsuyuki
AU - Matsukawa, Noriyuki
AU - Yoshida, Mari
N1 - Funding Information:
This research was supported by Japan Agency for Medical Research and Development (AMED) under Grant Number JP18dm0107105 and JP16kk0205009 (M. Yoshida). This work was supported by Grants-in Aid from the Research Committee of Prion Disease and Slow Virus Infection, and CNS Degenerative Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan (Y. Iwasaki, M. Yoshida).
Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2020/1/15
Y1 - 2020/1/15
N2 - The existence of affected subjects with both abnormal prion protein (PrPSc) types has been reported, and their clinical features were somewhat similar to the dominant PrPSc type but varied in sporadic Creutzfeldt-Jakob disease (sCJD). Presently, the antemortem identification of both PrPSc types in sCJD is not possible. In this study, we attempted to clinically predict the concurrence of MM-type sCJD with another PrPSc type in the same individual. We retrospectively identified seven MM-type sCJD cases with both fine vacuole-type spongiform (FV) and large confluent vacuole-type spongiform change (LCV) among 49 sCJD cases. We reviewed clinical features, pathological findings, and radiological abnormalities in these seven cases. We also conducted a regional systemic study with five brains to associate the spongiform-change pattern with hyperintensity on magnetic resonance diffusion-weighted imaging (DWI) using the signal intensity index (SII). In the case series study, the one patient with dominant LCV showed longer disease duration, later onset of typical symptoms, no periodic sharp wave complexes in electroencephalography, and negative 14–3-3 protein findings compared to the six FV-dominant patients. LCV-dominant lesions tended to show higher intensity on DWI than did the FV-dominant lesions in respective patients. In the regional systemic study, LCV-dominant regions showed significantly higher SII on DWI than did the FV-dominant regions. In conclusion, mixed MM-type sCJD generally showed the clinical features of the phenotype that was dominant in pathological distribution. The SII may be clinically useful for investigating the concurrence of PrPSc type 2 in cases with the typical clinical course of MM1-type sCJD.
AB - The existence of affected subjects with both abnormal prion protein (PrPSc) types has been reported, and their clinical features were somewhat similar to the dominant PrPSc type but varied in sporadic Creutzfeldt-Jakob disease (sCJD). Presently, the antemortem identification of both PrPSc types in sCJD is not possible. In this study, we attempted to clinically predict the concurrence of MM-type sCJD with another PrPSc type in the same individual. We retrospectively identified seven MM-type sCJD cases with both fine vacuole-type spongiform (FV) and large confluent vacuole-type spongiform change (LCV) among 49 sCJD cases. We reviewed clinical features, pathological findings, and radiological abnormalities in these seven cases. We also conducted a regional systemic study with five brains to associate the spongiform-change pattern with hyperintensity on magnetic resonance diffusion-weighted imaging (DWI) using the signal intensity index (SII). In the case series study, the one patient with dominant LCV showed longer disease duration, later onset of typical symptoms, no periodic sharp wave complexes in electroencephalography, and negative 14–3-3 protein findings compared to the six FV-dominant patients. LCV-dominant lesions tended to show higher intensity on DWI than did the FV-dominant lesions in respective patients. In the regional systemic study, LCV-dominant regions showed significantly higher SII on DWI than did the FV-dominant regions. In conclusion, mixed MM-type sCJD generally showed the clinical features of the phenotype that was dominant in pathological distribution. The SII may be clinically useful for investigating the concurrence of PrPSc type 2 in cases with the typical clinical course of MM1-type sCJD.
KW - Abnormal prion protein type
KW - Creutzfeldt-Jakob disease
KW - Diffusion-weighted imaging
KW - MRI
KW - Neuropathology
KW - Spongiform change
UR - http://www.scopus.com/inward/record.url?scp=85074052237&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074052237&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2019.116515
DO - 10.1016/j.jns.2019.116515
M3 - Article
C2 - 31675505
AN - SCOPUS:85074052237
SN - 0022-510X
VL - 408
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
M1 - 116515
ER -